Healthcare and pharma stocks: prices and forecasts
Updated automatically · prices as of 08/11/2026
Sanofi, Novo Nordisk, Eli Lilly, AstraZeneca, Johnson & Johnson…
| Stock | Price | 1 month | Expected swing | Fall risk* |
|---|---|---|---|---|
| EssilorLuxottica EL.PA | €193.80 | +35.5% | ±9% | 15% |
| Bayer BAYN.DE | €55.58 | +30.5% | ±11% | 13% |
| Sanofi SAN.PA | €83.74 | +18.1% | ±7% | 8% |
| AstraZeneca AZN | $186.43 | +17.4% | ±7% | 10% |
| Eli Lilly LLY | $1,354.00 | +15.8% | ±11% | 12% |
| Novartis NVS | $162.55 | +13.6% | ±7% | 8% |
| Amgen AMGN | $460.42 | +13.0% | ±9% | 11% |
| Abbott ABT | $109.93 | +12.3% | ±8% | 11% |
| Merck KGaA MRK.DE | €148.75 | +9.6% | ±7% | 8% |
| Intuitive Surgical ISRG | $452.80 | +9.0% | ±10% | 17% |
| GSK GSK | $50.33 | +8.1% | ±8% | 9% |
| Johnson & Johnson JNJ | $276.22 | +7.7% | ±7% | 7% |
| AbbVie ABBV | $291.31 | +7.6% | ±8% | 8% |
| Pfizer PFE | $29.39 | +7.2% | ±7% | 8% |
| Thermo Fisher TMO | $694.76 | +6.6% | ±10% | 12% |
| UnitedHealth UNH | $394.15 | +6.3% | ±9% | 10% |
| Novo Nordisk NVO | $40.31 | +5.6% | ±9% | 16% |
| Merck MRK | $146.73 | +3.1% | ±9% | 13% |
* Risk of a fall of more than 10% over the next month. Swings and fall risk are what the AI forecasts best (calls checked in public). The direction of prices stays very uncertain. Not investment advice.